298 related articles for article (PubMed ID: 29701021)
61. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
Cho S; Shin J; Cho BK
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
[TBL] [Abstract][Full Text] [Related]
62. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
63. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
64. CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.
Klann TS; Black JB; Chellappan M; Safi A; Song L; Hilton IB; Crawford GE; Reddy TE; Gersbach CA
Nat Biotechnol; 2017 Jun; 35(6):561-568. PubMed ID: 28369033
[TBL] [Abstract][Full Text] [Related]
65. CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots.
Cai Y; Chen L; Liu X; Sun S; Wu C; Jiang B; Han T; Hou W
PLoS One; 2015; 10(8):e0136064. PubMed ID: 26284791
[TBL] [Abstract][Full Text] [Related]
66. High-throughput functional genomics using CRISPR-Cas9.
Shalem O; Sanjana NE; Zhang F
Nat Rev Genet; 2015 May; 16(5):299-311. PubMed ID: 25854182
[TBL] [Abstract][Full Text] [Related]
67. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
[TBL] [Abstract][Full Text] [Related]
68. Application of CRISPR genetic screens to investigate neurological diseases.
So RWL; Chung SW; Lau HHC; Watts JJ; Gaudette E; Al-Azzawi ZAM; Bishay J; Lin LT; Joung J; Wang X; Schmitt-Ulms G
Mol Neurodegener; 2019 Nov; 14(1):41. PubMed ID: 31727120
[TBL] [Abstract][Full Text] [Related]
69. Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment.
Wu X; Ma W; Mei C; Chen X; Yao Y; Liu Y; Qin X; Yuan Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):97. PubMed ID: 32487115
[TBL] [Abstract][Full Text] [Related]
70. Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment.
Xue VW; Wong SCC; Cho WCS
Expert Opin Ther Targets; 2020 Nov; 24(11):1147-1158. PubMed ID: 32893711
[TBL] [Abstract][Full Text] [Related]
71. [Development and applications of CRISPR/Cas9 library screening technology in cancer research].
Lei T; Xiao B; He Y; Qu J; Sun Z; Li L
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1381-1386. PubMed ID: 31852637
[TBL] [Abstract][Full Text] [Related]
72. A mouse geneticist's practical guide to CRISPR applications.
Singh P; Schimenti JC; Bolcun-Filas E
Genetics; 2015 Jan; 199(1):1-15. PubMed ID: 25271304
[TBL] [Abstract][Full Text] [Related]
73. A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization.
Šafarič Tepeš P; Sordella R
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34542533
[TBL] [Abstract][Full Text] [Related]
74. How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research.
Johansen KH
DNA Cell Biol; 2022 Jan; 41(1):53-57. PubMed ID: 34939826
[TBL] [Abstract][Full Text] [Related]
75. Decoding the noncoding genome via large-scale CRISPR screens.
Shukla A; Huangfu D
Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
[TBL] [Abstract][Full Text] [Related]
76. CRISPR/Cas9: a powerful tool in colorectal cancer research.
Hu Y; Liu L; Jiang Q; Fang W; Chen Y; Hong Y; Zhai X
J Exp Clin Cancer Res; 2023 Nov; 42(1):308. PubMed ID: 37993945
[TBL] [Abstract][Full Text] [Related]
77. Investigating Cellular Recognition Using CRISPR/Cas9 Genetic Screening.
Chong ZS; Wright GJ; Sharma S
Trends Cell Biol; 2020 Aug; 30(8):619-627. PubMed ID: 32595062
[TBL] [Abstract][Full Text] [Related]
78. CRISPR-Cas9: a promising genetic engineering approach in cancer research.
Ratan ZA; Son YJ; Haidere MF; Uddin BMM; Yusuf MA; Zaman SB; Kim JH; Banu LA; Cho JY
Ther Adv Med Oncol; 2018; 10():1758834018755089. PubMed ID: 29434679
[TBL] [Abstract][Full Text] [Related]
79. CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery.
Luo J
Trends Cancer; 2016 Jun; 2(6):313-324. PubMed ID: 28603775
[TBL] [Abstract][Full Text] [Related]
80. Identification of Drug Resistance Genes Using a Pooled Lentiviral CRISPR/Cas9 Screening Approach.
Kerek EM; Cromwell CR; Hubbard BP
Methods Mol Biol; 2021; 2381():227-242. PubMed ID: 34590280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
